Delivery Order SPE2DB20D1100-SPE2DB25FD5C5
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRODELVY 180 MG VIALS. The contract has a firm fixed price of $9,584.58 and a completion date of May 12, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,584.58, is for the delivery of 4,567,873,999 units of the medication TRODELVY 180 MG VIALS. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $9,584.58, and a performance period ending on May 14, 2025. This contract is not a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,014 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 180 mg vials of the drug TRODELVY. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- This is a Firm Fixed Price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the procurement of TRODELVY 180 MG VIALS. The contract has a ceiling value of $6,389.72 and a period of performance through June 20, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of TRODELVY 180 MG VIALS, a pharmaceutical product. The award, valued at $12,014.00, has a firm fixed price and an ultimate completion date of August 6, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TRODELVY 180 MG VIALS. The contract has a ceiling value of $6,007.00 and a period of performance ending on September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these specialized pharmaceutical products to support military treatment facilities and other federal healthcare programs. This delivery order is part of a larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $18,021.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TRODELVY 180 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,584.58 firm fixed-price delivery order is for the supply of TRODELVY 180MG VIAL 1S medical products, with a completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a prescription medication. It is a firm fixed price contract with a ceiling value of $15,974.30 and a performance period ending on July 22, 2025. The contract is not set aside for any small business or socioeconomic program. AmerisourceBergen holds...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5C5Delivery Order
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the supply of TRODELVY 180 MG VIALS, a pharmaceutical product, with a ceiling value of $12,779.44 and a completion date of August 7, 2025. The contract is a firm fixed-price delivery order, and it is not a set-aside contract. AmerisourceBergen Drug Corp has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 7/17/25 |